CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for SWK Holdings Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

SWK Holdings Corp
5956 Sherry Lane, Suite 650
Phone: (214) 217-7253p:214 217-7253 DALLAS, TX  75225  United States Ticker: SWKHSWKH
Business Summary
SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. The Company provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. The Company's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202512/31/2024YesYes---

Industries
SIC Code Description
7372 Prepackaged software
6159 Miscellaneous business credit institutions

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Laurie L.Dotter 64 1/1/2023 2/9/2022
President, Chief Executive Officer Joe D.Staggs 44 7/3/2024 9/1/2022
Chief Financial Officer AdamRice 44 7/3/2024 7/3/2024
Independent Director Jerry G.Albright 66 3/15/2023 3/15/2023
Independent Director Robert K.Hatcher 62 2/15/2022 2/15/2022

Subsidiaries
Business Name Address City State/Province Country
Enteris BioPharma, Inc. 83 Fulton Street Boonton NJ United States

Business Names
Business Name
Enteris BioPharma, Inc.
KANA Software, Inc.
SWK Advisors LLC
5 additional Business Names available in full report.

General Information
Number of Employees: 26 (As of 3/31/2025)
Outstanding Shares: 12,269,614 (As of 5/7/2025)
Shareholders: 76
Stock Exchange: NASD
Federal Tax Id: 770435679
Fax Number: (972) 687-7255
Email Address: info@kana.com


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 12, 2025